Strides Pharma Science Limited
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- ₹38.55 billion
- Book Value:
- Revenue TTM:
- Operating Margin TTM:
- Gross Profit TTM:
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Strides Pharma Science Limited had its IPO on under the ticker symbol 532531.
The company operates in the Other sector and Other industry. Strides Pharma Science Limited has a staff strength of 0 employees.
Shares of Strides Pharma Science Limited opened at ₹472.45 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹452.75 - ₹476.25, and closed at ₹456.75.
This is a -3.22% slip from the previous day's closing price.
A total volume of 45,785 shares were traded at the close of the day’s session.
In the last one week, shares of Strides Pharma Science Limited have increased by +3.02%.
Strides Pharma Science Limited's Key Ratios
Strides Pharma Science Limited has a market cap of ₹38.55 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Strides Pharma Science Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Strides Pharma Science Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Strides Pharma Science Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q0.33333333333333, Strides Pharma Science Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Strides Pharma Science Limited’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Strides Pharma Science Limited’s profitability.
Strides Pharma Science Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Strides Pharma Science Limited stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹66.38 billion
- Total Liabilities
- ₹29.90 billion
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Strides Pharma Science Limited ended 2023 with ₹66.38 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹66.38 billion while shareholder equity stood at ₹22.12 billion.
Strides Pharma Science Limited ended 2023 with ₹0 in deferred long-term liabilities, ₹29.90 billion in other current liabilities, 903030000.00 in common stock, ₹21.22 billion in retained earnings and ₹5.14 billion in goodwill. Its cash balance stood at ₹3.04 billion and cash and short-term investments were ₹4.59 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹11.40 billion.
Strides Pharma Science Limited’s total current assets stands at ₹32.43 billion while long-term investments were ₹0 and short-term investments were ₹1.43 billion. Its net receivables were ₹12.99 billion compared to accounts payable of ₹9.82 billion and inventory worth ₹11.47 billion.
In 2023, Strides Pharma Science Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Strides Pharma Science Limited paid ₹0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Strides Pharma Science Limited stock is currently trading at ₹456.75 per share. It touched a 52-week high of ₹487.1972 and a 52-week low of ₹487.1972. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹443.24 and 200-day moving average was ₹364.05 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Strides Pharma Science Limited
Similar Industry Stocks (Other)